Jochen G. Mainz

5.7k total citations · 2 hit papers
107 papers, 3.1k citations indexed

About

Jochen G. Mainz is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Physiology. According to data from OpenAlex, Jochen G. Mainz has authored 107 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Pulmonary and Respiratory Medicine, 29 papers in Otorhinolaryngology and 18 papers in Physiology. Recurrent topics in Jochen G. Mainz's work include Cystic Fibrosis Research Advances (78 papers), Sinusitis and nasal conditions (29 papers) and Tracheal and airway disorders (21 papers). Jochen G. Mainz is often cited by papers focused on Cystic Fibrosis Research Advances (78 papers), Sinusitis and nasal conditions (29 papers) and Tracheal and airway disorders (21 papers). Jochen G. Mainz collaborates with scholars based in Germany, United Kingdom and United States. Jochen G. Mainz's co-authors include Joachim Riethmüller, Assen Koitschev, Ute Graepler-Mainka, Corinna Engel, Vanya Icheva, Gloria Herrmann, Erich Gulbins, Lutz Nährlich, Constantin Adams and S. Heyder and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Jochen G. Mainz

91 papers receiving 3.1k citations

Hit Papers

Therapy of CF-Patients with Amitriptyline and Placebo - a... 2013 2026 2017 2021 2013 2013 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study
    2013 1.2k citations Jochen G. Mainz et al. profile →
  2. Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
    2013 369 citations Jane C. Davies, Claire Wainwright et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jochen G. Mainz Germany 23 2.4k 626 437 425 299 107 3.1k
Edward F. McKone United States 20 4.4k 1.8× 608 1.0× 57 0.1× 290 0.7× 407 1.4× 44 5.0k
Jennifer L. Taylor‐Cousar United States 31 2.8k 1.2× 432 0.7× 66 0.2× 154 0.4× 234 0.8× 126 3.3k
Hannah R. Wardill Australia 27 945 0.4× 775 1.2× 363 0.8× 165 0.4× 268 0.9× 92 2.0k
Janice L. Launspach United States 20 844 0.4× 418 0.7× 78 0.2× 295 0.7× 218 0.7× 31 1.8k
Scott H. Donaldson United States 33 3.1k 1.3× 761 1.2× 40 0.1× 163 0.4× 534 1.8× 99 4.0k
Isabelle Vachier France 32 1.5k 0.6× 514 0.8× 192 0.4× 376 0.9× 1.8k 6.0× 120 3.3k
Edmond H.H.M. Rings Netherlands 33 405 0.2× 730 1.2× 137 0.3× 637 1.5× 272 0.9× 125 2.8k
Yuzo Suzuki Japan 33 1.9k 0.8× 504 0.8× 32 0.1× 505 1.2× 1.0k 3.5× 189 3.9k
David P. Nichols United States 33 1.6k 0.7× 797 1.3× 29 0.1× 144 0.3× 275 0.9× 100 2.9k
Mirjam Stahl Germany 25 1.6k 0.7× 239 0.4× 76 0.2× 142 0.3× 168 0.6× 94 2.0k

Countries citing papers authored by Jochen G. Mainz

Since Specialization
Citations

This map shows the geographic impact of Jochen G. Mainz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen G. Mainz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen G. Mainz more than expected).

Fields of papers citing papers by Jochen G. Mainz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jochen G. Mainz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen G. Mainz. The network helps show where Jochen G. Mainz may publish in the future.

Co-authorship network of co-authors of Jochen G. Mainz

This figure shows the co-authorship network connecting the top 25 collaborators of Jochen G. Mainz. A scholar is included among the top collaborators of Jochen G. Mainz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jochen G. Mainz. Jochen G. Mainz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sermet‐Gaudelus, Isabelle, et al.. (2025). The validated French CFAbd‐Score reveals a lower burden of gastrointestinal symptoms in patients on Elexacaftor/Tezacaftor/Ivacaftor. Journal of Pediatric Gastroenterology and Nutrition. 82(1). 24–32.
2.
Ng, Christabella, Neele Dellschaft, Caroline L. Hoad, et al.. (2024). A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI). Journal of Cystic Fibrosis. 23(5). 984–990. 3 indexed citations
3.
4.
Burgel, Pierre‐Régis, Manfred Ballmann, Pavel Dřevı́nek, et al.. (2024). Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy. BMJ Open Respiratory Research. 11(1). e002049–e002049. 9 indexed citations
5.
Magro, Daniéla Oliveira, et al.. (2024). Cross-cultural adaptation and validation of the CFAbd-Score for gastrointestinal symptoms in patients with cystic fibrosis. Jornal de Pediatria. 101(1). 82–88.
6.
Wilschanski, Michael, À. Munck, Marco Cipolli, et al.. (2023). ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis. Clinical Nutrition. 43(2). 413–445. 32 indexed citations
7.
8.
Mainz, Jochen G., et al.. (2023). Respiratory Fungal Infections in Cystic Fibrosis: Diagnostic and Therapeutic Challenges. Current Fungal Infection Reports. 17(3). 202–213.
9.
Prenzel, Freerk, Uta Ceglarek, J. Hammermann, et al.. (2021). Audit of sweat chloride testing reveals analytical errors. Clinical Chemistry and Laboratory Medicine (CCLM). 59(8). 1376–1383.
10.
Ribeiro, Antônio Fernando, et al.. (2021). Diagnosing constipation in patients with cystic fibrosis applying ESPGHAN criteria. Journal of Cystic Fibrosis. 21(3). 497–501. 8 indexed citations
11.
Ng, Christabella, Neele Dellschaft, Caroline L. Hoad, et al.. (2020). Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging. Journal of Cystic Fibrosis. 20(4). 591–597. 26 indexed citations
12.
Suthoff, Ellison, Jochen G. Mainz, D. Cox, et al.. (2019). Caregiver Burden Due to Pulmonary Exacerbations in Patients with Cystic Fibrosis. The Journal of Pediatrics. 215. 164–171.e2. 13 indexed citations
13.
Michl, R., et al.. (2016). Clinical approach to the diagnosis and treatment of cystic fibrosis and CFTR-related disorders. Expert Review of Respiratory Medicine. 10(11). 1177–1186. 12 indexed citations
14.
Mainz, Jochen G., et al.. (2015). Rhinosinusitis bei Mukoviszidose. HNO. 63(11). 809–820. 5 indexed citations
15.
16.
Davies, Jane C., Claire Wainwright, Gerard J. Canny, et al.. (2013). Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation. American Journal of Respiratory and Critical Care Medicine. 187(11). 1219–1225. 369 indexed citations breakdown →
17.
Mainz, Jochen G. & Assen Koitschev. (2012). Pathogenesis and Management of Nasal Polyposis in Cystic Fibrosis. Current Allergy and Asthma Reports. 12(2). 163–174. 57 indexed citations
18.
Hentschel, Julia, Manfred Stuhrmann, Olaf Sommerburg, et al.. (2012). Homozygous CFTR mutation M348K in a boy with respiratory symptoms and failure to thrive. Disease-causing mutation or benign alteration?. European Journal of Pediatrics. 171(7). 1039–1046. 2 indexed citations
19.
Mainz, Jochen G., Julia Hentschel, Nina Cramer, et al.. (2011). Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation. Journal of Cystic Fibrosis. 11(2). 158–161. 57 indexed citations
20.
Mainz, Jochen G., et al.. (2010). Prevalence of CF-related chronic rhinosinusitis – results from a multicentre interdisciplinary study. Journal of Cystic Fibrosis. 9. S118–S118. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward F. McKone Breakdown of academic impact, for papers by Jennifer L. Taylor‐Cousar Breakdown of academic impact, for papers by Hannah R. Wardill Breakdown of academic impact, for papers by Janice L. Launspach Breakdown of academic impact, for papers by Scott H. Donaldson Breakdown of academic impact, for papers by Isabelle Vachier Breakdown of academic impact, for papers by Edmond H.H.M. Rings Breakdown of academic impact, for papers by Yuzo Suzuki Breakdown of academic impact, for papers by David P. Nichols Breakdown of academic impact, for papers by Mirjam Stahl
Rankless by CCL
2026